11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

11 trials found

diseases per page:

Showing 1 to 10 of 11 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05374590 (ClinicalTrials.gov)	August 18, 2022	1/4/2022	Evaluating Long-term Safety of Efgartigimod Administered Intravenously in Children With Generalized ...	A Long-term, Single-Arm, Open-label, Multicenter, Follow-on Trial of ARGX-113-2006 to Evaluate Safet ...	Generalized Myasthenia Gravis	Biological: Efgartigimod IV	argenx	NULL	Recruiting	2 Years	18 Years	All	12	Phase 2/Phase 3	Netherlands;Poland
2	NCT04980495 (ClinicalTrials.gov)	December 16, 2021	19/7/2021	An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimo ...	A Phase 3b, Randomized, Open-label, Parallel-Group Study to Evaluate Different Dosing Regimens of In ...	Generalized Myasthenia Gravis	Biological: Efgartigimod concentrate for solution for infusion 20 mg/mL	argenx	NULL	Recruiting	18 Years	N/A	All	72	Phase 3	United States;Austria;Belgium;Canada;France;Georgia;Germany;Italy;Netherlands;Poland;Spain
3	EUCTR2021-002504-12-PL (EUCTR)	01/12/2021	24/09/2021	An open-label study to investigate the clinical efficacy of different dosing regimens of efgartigimo ...	A Phase 3b, Randomized, Open-label, Parallel-Group Study to Evaluate Different Dosing Regimens of In ...	Generalized Myasthenia Gravis (gMG) MedDRA version: 21.1;Level: PT;Classification code 10028417;Term ...	Product Code: ARGX-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	72	Phase 3	France;United States;Canada;Spain;Belgium;Poland;Austria;Georgia;Netherlands;Germany;United Kingdom; ...
4	EUCTR2021-002504-12-ES (EUCTR)	26/11/2021	02/12/2021	An open-label study to investigate the clinical efficacy of different dosing regimens of efgartigimo ...	A Phase 3b, Randomized, Open-label, Parallel-Group Study to Evaluate Different Dosing Regimens of In ...	Generalized Myasthenia Gravis (gMG) MedDRA version: 21.1;Level: PT;Classification code 10028417;Term ...	Product Code: ARGX-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	72	Phase 3	France;United States;Canada;Poland;Belgium;Spain;Austria;Georgia;Netherlands;Germany;United Kingdom; ...
5	NCT04833894 (ClinicalTrials.gov)	October 26, 2021	16/3/2021	Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intraveno ...	Open-label Uncontrolled Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Activity o ...	Generalized Myasthenia Gravis	Biological: Efgartigimod IV	argenx	NULL	Recruiting	2 Years	18 Years	All	12	Phase 2/Phase 3	United States;Austria;Belgium;France;Georgia;Germany;Italy;Netherlands;Poland;Spain
6	EUCTR2020-004085-19-DE (EUCTR)	31/05/2021	29/01/2021	Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 Administered Subcutaneously as Co ...	A Phase 3, Randomized, Open-label, Parallel-Group Study to Compare the Pharmacodynamics, Pharmacokin ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: EFGARTIGIMOD ALFA Product Name: Efgartigimod I ...	argenx BV	NULL	Not Recruiting			Female: yes Male: yes	110	Phase 3	Serbia;United States;Czechia;Spain;Russian Federation;United Kingdom;Italy;Hungary;Belgium;Poland;Ge ...
7	EUCTR2020-004085-19-IT (EUCTR)	26/04/2021	07/06/2021	Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 Administered Subcutaneously as Co ...	A Phase 3, Randomized, Open-Label, Parallel-Group Study to Compare the Pharmacodynamics, Pharmacokin ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Efgartigimod PH20 SC Product Code: [NA] INN or Proposed INN: EFGARTIGIMOD ALFA Product Na ...	ARGENX BV	NULL	Not Recruiting			Female: yes Male: yes	76	Phase 3	Serbia;United States;Czechia;Spain;Russian Federation;United Kingdom;Italy;Hungary;Belgium;Poland;Ge ...
8	EUCTR2020-004085-19-NL (EUCTR)	19/03/2021	05/01/2021	Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 Administered Subcutaneously as Co ...	A Phase 3, Randomized, Open-Label, Parallel-Group Study to Compare the Pharmacodynamics, Pharmacokin ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: EFGARTIGIMOD ALFA Product Name: Efgartigimod I ...	argenx BV	NULL	Not Recruiting			Female: yes Male: yes	76	Phase 3	Serbia;United States;Czechia;Spain;Russian Federation;United Kingdom;Italy;Hungary;Belgium;Poland;Ge ...
9	EUCTR2020-004085-19-BE (EUCTR)	16/03/2021	12/01/2021	Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 Administered Subcutaneously as Co ...	A Phase 3, Randomized, Open-Label, Parallel-Group Study to Compare the Pharmacodynamics, Pharmacokin ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: EFGARTIGIMOD ALFA Product Name: Efgartigimod I ...	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	76	Phase 3	Georgia;Germany;Netherlands;Serbia;United States;Czechia;Spain;Russian Federation;United Kingdom;Ita ...
10	EUCTR2020-004085-19-HU (EUCTR)	24/02/2021	29/12/2020	Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 Administered Subcutaneously as Co ...	A Phase 3, Randomized, Open-Label, Parallel-Group Study to Compare the Pharmacodynamics, Pharmacokin ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: EFGARTIGIMOD ALFA Product Name: Efgartigimod I ...	argenx BV	NULL	Not Recruiting			Female: yes Male: yes	110	Phase 3	Serbia;United States;Czechia;Spain;Russian Federation;United Kingdom;Italy;Hungary;Belgium;Poland;Ge ...

First Previous1 2Next Last